The observation of two-body collisions is a prerequisite for investigating many types of molecular dynamics. One of the most intriguing prospects is the possibility of initiating evaporative cooling 6 , whereby even lower temperatures than that achieved by the authors could be obtained by removing high-energy molecules from the trap. Unfortunately, this process remains to be demonstrated. Moreover, the present work suggests that efficient evaporative cooling might not be feasible in the case of oxygen molecules, because many of the collisions reduce the number of trapped molecules without lowering the temperature.
Segev and colleagues managed to trap a large number of molecules (about one billion) at a high density. This condition, together with the long lifetime of the trap, is indispensable for pushing cold-molecule research forwards. Until now, such conditions have never been achieved simultaneously without the use of laser cooling. The authors' work should therefore be viewed as yet another landmark in this field.
In the past few years, other methods for producing cold molecules have also made breakthroughs 7 . For example, an exotic state of matter known as a quantum degenerate gas, comprising ground-state molecules, has been made by assembling cold atoms 8 . And single molecules have been loaded into traps called optical tweezers with the help of direct laser cooling of ground-state molecules 9 . None of these methods, including the one reported by Segev and colleagues, can be applied to all types of molecule. But putting them all together, a wide range of cold molecules will become available for study. After more than two decades of hard effort, it is now time to start exploring the great promise of cold molecules in many fundamental and practical applications 2, 7 . (Fig. 1) . The mechanism responsible for such induction is unknown.
The authors report that, when human breast cancer cells expressing FWE Win were transplanted into the breast region of mice engineered to express human FWE Lose , the transplanted cells generated aggressive tumours. By contrast, less aggressive tumours were generated if FWE Lose -expressing human breast cancer cells were transplanted into mouse breast tissue that expressed human FWE Win . This indicates that it is the combination of high expression of FWE Win in tumours and high expression of FWE Lose in the tissue that surrounds them that aids cancer growth.
When the authors engineered human cancer cells to block expression of FWE and transplanted these cells into mouse legs, the cancer cells showed diminished growth and reduced capacity for migration (termed meta stasis) to a secondary site compared with transplants of human cancer cells in which FWE expression was not blocked. When chemotherapy was also administered, growth of the engineered human cancer cells in the mouse legs was substantially inhibited.
Madan and colleagues suggest that FWE should be investigated as a possible therapeutic target in human tumours and in the tissues that surround them. However, whether human FWE can be selectively targeted using antibodies or chemical compounds should be examined before a clinical approach can be considered.
The 4 suggests that membrane proteins of unknown identity can distinguish between winner and loser versions of FWE expressed on neighbouring cells. If such proteins exist, their identification will be necessary to understand how FWE-mediated cell competition functions.
Another key question is whether cancerpromoting mutations trigger FWE-mediated cell competition in mammals, and, if so, which mutations are responsible. There are reports that abnormal expression of the tumour-promoting proteins Myc or Wnt is involved in FWE-related cell competition in D. melanogaster [4] [5] [6] . Analyses of tumour cells from patients might shed light on whether this also occurs in humans.
Madan and colleagues' work should motivate researchers to analyse human-tumour samples to determine the involvement of FWE in cell competition and cancer development. If antibodies could be developed to specifically recognize human FWE Lose proteins, this would greatly aid such studies. However, generating such antibodies is not straightforward, and the authors discuss the technical hurdles that would need to be overcome.
In D. melanogaster, other proteins in addition to FWE can regulate cell competition 7, 8 , and further studies in human cancer cells will be needed to gain a more complete picture of mammalian cell competition. 
